Anders Jack — SEC Form 4 filings
SEC reporting owner CIK 1800668. 21 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-03-05 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 23 legs across 18 filings — 102,437 shares, $9,032,304 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 9,496 shares @ $168.20 ($1,597,188) in Revolution Medicines, Inc., filed 2026-06-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | 21 | — | 23 legs · 102,437 sh · $9,032,304 | 26 |
Form 4 filings — Anders Jack
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 61 @ $195 · Sale (S): 3,992 @ $199.30 | EDGAR |
| 2026-06-26 | 4 | Revolution Medicines, Inc. (RVMD) | Option exercise (M): 20,000 @ $18.56 · Sale (S): 4,553 @ $167.34 · Sale (S): 9,496 @ $168.20 · Sale (S): 5,651 @ $169.24 · Sale (S): 300 @ $170.32 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 2,722 @ $156.12 | EDGAR |
| 2026-03-19 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 2,753 @ $99.48 | EDGAR |
| 2026-03-03 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 20,200 @ $0 · Grant/award (A): 45,400 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Revolution Medicines, Inc. (RVMD) | Option exercise (M): 10,000 @ $42.45 · Sale (S): 10,000 @ $98 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 3,104 @ $77.09 | EDGAR |
| 2025-11-26 | 4 | Revolution Medicines, Inc. (RVMD) | Option exercise (M): 5,418 @ $17 · Sale (S): 5,418 @ $74 · Option exercise (M): 5,418 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Revolution Medicines, Inc. (RVMD) | Option exercise (M): 10,000 @ $17 · Sale (S): 10,000 @ $64 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-09-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 2,320 @ $45.82 | EDGAR |
| 2025-09-04 | 4 | Revolution Medicines, Inc. (RVMD) | Option exercise (M): 2,814 @ $2.68 · Option exercise (M): 1,948 @ $4.73 · Sale (S): 4,762 @ $40.02 · Option exercise (M): 3,189 @ $4.73 · Option exercise (M): 2,049 @ $17 · Sale (S): 5,238 @ $40.17 · +4 more | EDGAR |
| 2025-06-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 2,170 @ $39.83 | EDGAR |
| 2025-03-19 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 1,864 @ $39.04 | EDGAR |
| 2025-03-04 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 20,400 @ $0 · Grant/award (A): 71,400 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 2,635 @ $45.40 | EDGAR |
| 2024-10-15 | 4 | Revolution Medicines, Inc. (RVMD) | Option exercise (M): 10,000 @ $2.68 · Sale (S): 10,000 @ $50.30 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 2,244 @ $44.19 | EDGAR |
| 2024-06-20 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 1,893 @ $37.39 | EDGAR |
| 2024-05-03 | 4 | Revolution Medicines, Inc. (RVMD) | Option exercise (M): 10,000 @ $2.68 · Sale (S): 10,000 @ $40.03 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 1,261 @ $31.58 | EDGAR |
| 2024-03-05 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 26,400 @ $0 · Grant/award (A): 92,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1800668 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →